FDA-cleared, first-line CBT-I for Medicare patients with insomnia

Offer your patients instant access to safe and effective, fully digital, FDA-cleared insomnia treatment with SleepioRx.

Request Demo

FDA-Cleared

500K+ Patients

Treated & supported

App Store Rating

Vetted & Secure

HIPAA compliant &
HITRUST certified

Reimbursable

by Insurance

Safe and effective treatment for your Medicare patients with insomnia

Immediate access to evidence-based care for patients

Get patients instant access to cognitive behavioral therapy (CBT), the gold-standard treatment for insomnia disorder¹

CMS-approved reimbursable care option for clinicians

Address high patient demand and waitlists with reimbursable, FDA-cleared treatment under new CMS codes

Scalable insomnia treatment for your practice

Expand access to high-quality insomnia treatment efficiently, without overburdening clinicians in your practice

Explore Use Cases

Read FAQs

FDA-CLeared + reimbursable  digital treatment

Sleepio RX

Proven to help 76% of insomnia patients achieve clinical improvement with no serious side effects²

clinical use cases FOR SLEEPIO RX

Expand access and close care gaps

First-line care

SleepioRx + DaylightRx provide first-line recommended treatment for insomnia & anxiety

PCPs, Psychiatrists, Sleep med

Waitlist support

SleepioRx + DaylightRx provide support for patients on long waitlists

Therapists, Psychiatrists, Sleep med

Therapy reinforcement

SleepioRx + DaylightRx reinforce therapy skills and support practice of CBT between sessions

Therapists, Sleep med

Rx combination
or discontinuation

In combo with meds, SleepioRx + DaylightRx improve outcomes or support discontinuation

PCPs, Psychiatrists, Sleep med

Comorbid condition
treatment

SleepioRx + DaylightRx reinforce therapy skills and support practice of CBT between sessions

Therapists, Psychiatrists

Maintenance support

Offered ahead of treatment termination, SleepioRx + DaylightRx help maintain CBT skills

Therapists, Psychiatrists, Sleep med

Request Demo

HEAR FROM CLINICAL EXPERTS

The impact of SleepioRx in practice

SUPPORT CLINICAL PRACTICE

Trusted, clinically proven care

Read the Research

100+

Peer-reviewed publications demonstrating safety + efficacy

76%

Clinical improvement rate²

References in clinical guidelines like the American College of Physicians¹

What are SleepioRx and DaylightRx?

SleepioRx¹ and DaylightRx² are FDA-cleared digital treatments for insomnia disorder and generalized anxiety disorder, respectively, delivering guideline-recommended cognitive behavioral therapy (CBT) through video and audio lessons in mobile apps. Designed by sleep and anxiety experts, the treatments help patients understand unhealthy patterns and address the thoughts and behaviors that sustain insomnia and anxiety. CBT techniques delivered in an engaging and interactive format help patients overcome insomnia and anxiety, quickly.

^{1. SleepioRx is a digital therapeutic intended for the treatment of chronic insomnia/insomnia disorder as an adjunct to usual care in patients aged 18 and older. SleepioRx is a prescription device delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) and can be made available on the order of a licensed healthcare provider. Patients should read the instructions for use for full information.
2. DaylightRx is a prescription device delivering Cognitive Behavioral Therapy and can be made available on the order of a licensed healthcare provider. DaylightRx is a digital therapeutic intended to treat generalized anxiety disorder (GAD) by improving a patient's GAD symptoms as an adjunct to usual care in patients aged 22 years and older. Patients should read the instructions for use for full information.}

What evidence is there showing that SleepioRx and DaylightRx work?

Which insurers cover SleepioRx and DaylightRx?

What types of providers can authorize use of these products and bill for reimbursement?

What are SleepioRx and DaylightRx?

Ready to cover first-line treatments for behavioral health conditions?

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

1. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016 Jul 19;165(2):125-33. doi: 10.7326/M15-2175. Epub 2016 May 3. PMID: 27136449

2. DeGeorge KC, Grover M, Streeter GS. Generalized Anxiety Disorder and Panic Disorder in Adults. Am Fam Physician. 2022 Aug;106(2):157-164. PMID: 35977134.

3. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep, 35(6), 769–781.4. Carl, J. R., Miller, C. B., Henry, A. L., Davis, M. L., Stott, R., Smits, J. A. J., Emsley, R., Gu, J., Shin, O., Otto, M. W., Craske, M. G., Saunders, K. E. A., Goodwin, G. M., & Espie, C. A. (2020). Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trial. Depression and anxiety, 37(12), 1168–1178. https://doi.org/10.1002/da.23079

5. Internal Data, compared to network averages, Nov 2023.

6. Internal Data, observed in independently conducted HEOR study of digital program in an employer population, May 2020.

7. Unpublished RCT data, Dec 2023. Stat reflects a 25% improvement in scores on a validated screening measure. Screening tools alone are not sufficient to diagnose depression.

Sleepio, Daylight, and Spark Direct are digital programs that may help individuals live well with mental health conditions and symptoms by providing them with cognitive and behavioral techniques that can improve sleep, feelings of worry and anxiety, and mood, respectively. Sleepio, Daylight, and Spark Direct have not been reviewed or approved by the Food & Drug Administration and are not intended to diagnose or treat any medical condition. Please read the instructions for use.

DOC-XXXX Effective May 2025

FDA-cleared, first-line CBT-I for Medicare patients with insomnia

FDA-CLeared + reimbursable digital treatment

Sleepio RX

HEAR FROM CLINICAL EXPERTS

The impact of SleepioRx in practice

FDA-CLeared + reimbursable  digital treatment